
|Podcasts|April 21, 2021
Dr. Robert J. Hamilton on statin use in men starting ADT for prostate cancer
Author(s)Urology Times staff
Hamilton discusses findings from a recent study published in European Urology.
Advertisement
“The patients who use statins had longer overall survival, longer prostate cancer-specific survival, and a trend towards longer time before they became castration resistant,” Robert J. Hamilton, MD, MPH, says in this podcast. Hamilton is an associate professor of urology at the University of Toronto.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
John Sfakianos, MD, discusses evolving management of recurrent LG-IR-NMIBC
2
AI-generated profiles impersonate female urologists to market ED products online
3
App-based intervention aims to increase PSA screening among Black men
4
Interpreting real-world evidence in ARPI treatment decisions, with Martin Schoen, MD, PhD
5






